- Actavis (ACT) has agreed to sell its generic-drug operations in seven western-European countries to India's Aurobindo Pharma for around €30M ($41M).
- The countries are France, Italy, Spain, Portugal, Belgium, Germany and Holland.
- "This transaction will permit Actavis to focus management time and resources to support accelerated investment in driving faster growth of other markets, including Central and Eastern Europe and Southeast Asia," Actavis said.
- News of the deal comes after Actavis said it intends to end its presence in China due to the difficult business climate. (PR)
Actavis sells generic-pharma ops in seven European markets
From other sites
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
at CNBC.com (Jan 26, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs